Preventive Antibacterial Therapy in Acute Ischemic Stroke: A Randomized Controlled Trial

Background Pneumonia is a major risk factor of death after acute stroke. In a mouse model, preventive antibacterial therapy with moxifloxacin not only prevents the development of post-stroke infections, it also reduces mortality, and improves neurological outcome significantly. In this study we investigate whether this approach is effective in stroke patients. Methods Preventive ANtibacterial THERapy in acute Ischemic Stroke (PANTHERIS) is a randomized, double-blind, placebo-controlled trial in 80 patients with severe, non-lacunar, ischemic stroke (NIHSS>11) in the middle cerebral artery (MCA) territory. Patients received either intravenous moxifloxacin (400 mg daily) or placebo for 5 days starting within 36 hours after stroke onset. Primary endpoint was infection within 11 days. Secondary endpoints included neurological outcome, survival, development of stroke-induced immunodepression, and induction of bacterial resistance. Findings On intention-to treat analysis (79 patients), the infection rate at day 11 in the moxifloxacin treated group was 15.4% compared to 32.5% in the placebo treated group (p = 0.114). On per protocol analysis (n = 66), moxifloxacin significantly reduced infection rate from 41.9% to 17.1% (p = 0.032). Stroke associated infections were associated with a lower survival rate. In this study, neurological outcome and survival were not significantly influenced by treatment with moxifloxacin. Frequency of fluoroquinolone resistance in both treatment groups did not differ. On logistic regression analysis, treatment arm as well as the interaction between treatment arm and monocytic HLA-DR expression (a marker for immunodepression) at day 1 after stroke onset was independently and highly predictive for post-stroke infections. Interpretation PANTHERIS suggests that preventive administration of moxifloxacin is superior in reducing infections after severe non-lacunar ischemic stroke compared to placebo. In addition, the results emphasize the pivotal role of immunodepression in developing post-stroke infections. Trial Registration Controlled-Trials.com ISRCTN74386719

[1]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[2]  Edgar Brunner,et al.  Nonparametric analysis of longitudinal data in factorial experiments , 2012 .

[3]  Adnan I. Qureshi,et al.  Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .

[4]  Ulrich Dirnagl,et al.  Stroke-Induced Immunodepression: Experimental Evidence and Clinical Relevance , 2007, Stroke.

[5]  Á. Chamorro,et al.  Catecholamines, infection, and death in acute ischemic stroke , 2007, Journal of the Neurological Sciences.

[6]  J. Grotta,et al.  Established treatments for acute ischaemic stroke , 2007, The Lancet.

[7]  U. Dirnagl,et al.  Stroke Propagates Bacterial Aspiration to Pneumonia in a Model of Cerebral Ischemia , 2006, Stroke.

[8]  D. Bowton,et al.  Diagnosis and treatment of ventilator-associated pneumonia. , 2006, Chest.

[9]  N. Voirin,et al.  Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock , 2006, Intensive Care Medicine.

[10]  Á. Chamorro,et al.  Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? , 2006, Stroke.

[11]  M. Uchino,et al.  Intermittent oro‐esophageal tube feeding in acute stroke patients – a pilot study , 2006, Acta neurologica Scandinavica.

[12]  U. Dirnagl,et al.  Central nervous system injury-induced immune deficiency syndrome , 2005, Nature Reviews Neuroscience.

[13]  Karen Furie,et al.  Formal Dysphagia Screening Protocols Prevent Pneumonia , 2005, Stroke.

[14]  Á. Chamorro,et al.  The Early Systemic Prophylaxis of Infection After Stroke Study: A Randomized Clinical Trial , 2005, Stroke.

[15]  S. Lewis,et al.  Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial , 2005, The Lancet.

[16]  P. Heuschmann,et al.  Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. , 2004, Archives of internal medicine.

[17]  E. Ringelstein,et al.  Pneumonia in acute stroke patients fed by nasogastric tube , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  H. Diener,et al.  Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial , 2004, European journal of neurology.

[19]  A. Lekkou,et al.  Cytokine Production and Monocyte HLA-DR Expression as Predictors of Outcome for Patients with Community-Acquired Severe Infections , 2004, Clinical Diagnostic Laboratory Immunology.

[20]  U. Dirnagl,et al.  Preventive Antibacterial Treatment Improves the General Medical and Neurological Outcome in a Mouse Model of Stroke , 2003, Stroke.

[21]  M. Kaste,et al.  Acute Treatment of Ischaemic Stroke , 2003, Cerebrovascular Diseases.

[22]  U. Dirnagl,et al.  Stroke-induced Immunodeficiency Promotes Spontaneous Bacterial Infections and Is Mediated by Sympathetic Activation Reversal by Poststroke T Helper Cell Type 1–like Immunostimulation , 2003, The Journal of experimental medicine.

[23]  M. Okada,et al.  Swallowing disorders post orotracheal intubation in the elderly , 2003, Intensive Care Medicine.

[24]  J. Sejvar,et al.  Risk of Elective Major Noncardiac Surgery After Coronary Stent Insertion , 2012 .

[25]  M. I. Norlinah,et al.  The predictors of early infection after an acute ischaemic stroke. , 2003, Singapore medical journal.

[26]  R. Hetzer,et al.  Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients , 2003, Cytometry. Part B, Clinical cytometry.

[27]  Subir Ghosh,et al.  Nonparametric Analysis of Longitudinal Data in Factorial Experiments , 2003, Technometrics.

[28]  W. Heiss,et al.  Nosocomial Pneumonia After Acute Stroke: Implications for Neurological Intensive Care Medicine , 2003, Stroke.

[29]  D W Baker,et al.  The effect of pneumonia on mortality among patients hospitalized for acute stroke , 2003, Neurology.

[30]  W. Fu,et al.  Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli. , 2002, The Journal of antimicrobial chemotherapy.

[31]  E. Goldstein,et al.  In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria. , 2000, International journal of antimicrobial agents.

[32]  Michael J Fine,et al.  Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  G. Murray,et al.  Medical complications after stroke: a multicenter study. , 2000, Stroke.

[34]  H. Arai,et al.  Relation between incidence of pneumonia and protective reflexes in post‐stroke patients with oral or tube feeding , 2000, Journal of internal medicine.

[35]  W. Hacke,et al.  Fever and infection early after ischemic stroke , 1999, Journal of the Neurological Sciences.

[36]  J. Marrugat,et al.  Timing for fever-related brain damage in acute ischemic stroke. , 1998, Stroke.

[37]  K. Chua,et al.  Clinical characteristics and functional outcome of stroke patients 75 years old and older. , 1998, Archives of physical medicine and rehabilitation.

[38]  R. Adams,et al.  Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. , 1998, Stroke.

[39]  S. Maxwell,et al.  Quantitative aspiration during sleep in normal subjects. , 1997, Chest.

[40]  C. Warlow,et al.  Complications after acute stroke. , 1996, Stroke.

[41]  K. Asadullah,et al.  Very low monocytic HLA-DR expression indicates high risk of infection--immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy. , 1995, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[42]  J. Pruvo,et al.  Early predictors of death and disability after acute cerebral ischemic event. , 1995, Stroke.

[43]  Wan Ariffin Bin Abdullah.  Singapore Med J , 1993 .

[44]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[45]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[46]  K. Pierce,et al.  Pharyngeal aspiration in normal adults and patients with depressed consciousness. , 1978, The American journal of medicine.

[47]  D R Taves,et al.  Minimization: A new method of assigning patients to treatment and control groups , 1974, Clinical pharmacology and therapeutics.

[48]  H. Lilliefors.  On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown , 1967 .

[49]  M. Kaste,et al.  Acute treatment of ischaemic stroke. European Stroke Initiative. , 2004, Cerebrovascular Diseases.

[50]  K. Asadullah,et al.  Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.